£5.5M
The seed round was co-led by Montage Ventures and AIX Ventures to fund asset expansion and clinical trials.
Ignota Labs uses artificial intelligence to turnaround failed pharmaceutical drugs.
Ignota Labs is a Cambridge-based biotechnology firm that applies artificial intelligence and machine learning to turnaround failed drug candidates. Its platform identifies the root causes of drug toxicity to revive abandoned pharmaceutical assets.
Sam Windsor
CEO and Co-Founder
The seed round was co-led by Montage Ventures and AIX Ventures to fund asset expansion and clinical trials.